Pharmascience Losartan Product Recall (2019-03-08) Mar 8, 2019 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength 498285, 600047, 600091, 603894, 612025, 612031, 612679, 616743 Recalling Firm Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA Marketing Authorization Holder Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA B. PMS-Losartan 50mg Tablet Tablet DIN 02309769 Losartan potassium 50mg 498864, 602668, 603816, 605298, 605300, 613935, 613936 Recalling Firm Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA Marketing Authorization Holder Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA C. PMS-Losartan 100mg Tablet Tablet DIN 02309777 Losartan potassium 100mg 498294, 605342, 611944 Recalling Firm Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA Marketing Authorization Holder Pharmascience Inc. 100, 6111 Royalmount Avenue Montreal H4P 2T4 Quebec CANADA A. PMS-Losartan 25mg Tablet Tablet DIN 02309750 Losartan potassium 25mg
Recalled Products
PMS-Losartan 25mg Tablet
PMS-Losartan 50mg Tablet
PMS-Losartan 100mg Tablet
Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as “NMBA”) above the acceptable level.